POLISCOPE
Back to bills
Part ofHealth →

The civic record

Read. Follow. Verify.
Did Not Advance

West Virginia Bill HB 4643 requires placebo studies and establishes liability for liability shield products

Original title: Relating to liability shield products

Last action · January 21, 2026: To House JudiciarySponsor: Evan Worrell

Introduced
Committee
Floor Vote
Passed
Law

Track this bill to get notified when it advances a stage. One tap to stop, anytime.

Public stanceCommunity reactions are separate from the official record and reporting.

What This Bill Proposed

House Bill 4643 requires manufacturers of s to complete five-year placebo-controlled studies, submit compliance reports, and allow individuals the right to refuse such products without coercion, with enforcement via the Attorney General and civil lawsuits beginning in 2032.

Why it matters

Manufacturers face civil penalties up to $100,000 per violation for failing to comply with testing and reporting mandates, while residents gain the legal right to refuse s and sue for compensatory damages and injunctive relief.

Background
  • House Bill 4643 was introduced in the West Virginia Legislature during the 2026 Regular Session by Delegate Worrell and referred to the Committee on the Judiciary then Finance. context

Who It Would Have Affected

Groups the bill's text would have affected, as described in the record. Being affected is not a position for or against it.

Directly affected

Manufacturers of liability shield products

Manufacturers must conduct five-year placebo-controlled studies, submit compliance reports to the state, and face potential civil penalties of up to $100,000 per violation.

Directly affected

Department of Health

The department is required to monitor adverse outcomes, publish surveillance data, issue safety alerts, and establish monitoring policies.

Directly affected

Residents of West Virginia

Individuals gain the explicit legal right to refuse liability shield products without coercion and can bring civil actions for compensatory damages and injunctive relief.

Key Facts

You don't have to trust us. Each fact below is taken straight from the official document - click any one to see the exact passage, highlighted in the original.

Frequently Asked Questions

What is a liability shield product under this bill?
It is defined as a medical, pharmaceutical, biological, or technological product that has been designated as immune from liability under federal law.
Can residents refuse to receive a liability shield product?
Yes, an individual may refuse a and cannot be subjected to coercion or threats to use it.
What penalties do manufacturers face for non-compliance?
Beginning January 1, 2032, the Attorney General may bring an action for injunctive relief, civil penalties up to $100,000 per violation, and attorney's fees and costs.

What else do you want to know?

News Coverage

Where This Stands

This bill did not become law - Died at adjournment · in House committee.

Procedural history

4 actions
  1. Jan 21, 2026HouseCommittee
    To House Judiciary
  2. Jan 21, 2026HouseIntroduced
    Introduced in House
  3. Jan 21, 2026HouseCommittee
    To Judiciary then Finance
  4. Jan 21, 2026HouseIntroduced
    Filed for introduction

Version history

Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.

View official text →

Lobbying Activity

No state lobbying filings in our records match this bill. Federal lobbying reports (LDA) cover Congress, so they are not listed on state bills.

Full breakdown

Who this bill affects and the strongest case for and against it, written only from the bill’s own text.

Sponsors

Discoveries

1 pattern noticed across the record

Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.

policy shift95% confidence

Imposition of State-Level Clinical Study Mandates

The bill creates an unusual state-level requirement for five-year placebo-controlled studies on products that already possess federal liability shields.

Connected Entities

United States Department of Health and Human Services, Cabinet for Health and Family Services, West Virginia Health Information Network and 4 more
OrganizationUnited States Department of Health and Human Services“Parent federal department for the FDA and CDC.”Map →
OrganizationCabinet for Health and Family Services“Defined as the Cabinet in the article definitions.”Map →
OrganizationWest Virginia Health Information Network“Utilized by the department to monitor and track adverse outcomes.”Map →
OrganizationCenters for Disease Control and Prevention“Cosponsor of the Vaccine Adverse Event Reporting System.”Map →
PersonAttorney General“Authorized to bring enforcement actions for violations beginning January 1, 2032”Map →
OrganizationFood and Drug Administration“Cosponsor of the Vaccine Adverse Event Reporting System.”Map →
OrganizationDepartment of Health“Responsible for monitoring adverse outcomes, issuing alerts, publishing data, an”Map →

Sources

Open source document

www.wvlegislature.gov

Analysis Score

0–100
  • Significance20
    Lowered because this bill did not pass (its text scored 75)
  • Controversy80
    Intensity of disagreement among stakeholders
  • Entertainment10
    Compellingness for a non-policy-wonk reader
  • Buzz45
    Current news / social attention level

Publisher tools

Share or embed this record

POLISCOPE publisher tools

Share or embed this record